Browse > Article

Comparison of Analysis Methods for Detection of Replication Competent Virus and Functional Titers of HIV-l Based Lentivirus Vector  

Chang Seok Kee (Korea Food & Drug Administration)
Oh Il Ung (Korea Food & Drug Administration)
Jeong Jayoung (Korea Food & Drug Administration)
Ahn Kwang Soo (Korea Food & Drug Administration)
Sohn Yeowon (Korea Food & Drug Administration)
Publication Information
YAKHAK HOEJI / v.49, no.3, 2005 , pp. 217-224 More about this Journal
Abstract
Human Immunodeficiency Virus type 1 (HIV-l) based lentivirus vector has demonstrated great potential as gene therapy vectors mediating efficient gene delivery and long-term transgene expression in both dividing and nondividing cells. However, for clinical studies it must be confirmed that vector preparations are safe and not contaminated by replication competent lentivirus (RCL) related to the parental pathogenic virus, HIV-l. In this study, we would like to establish the method for titration and RCL detection of lentivirus vector. The titration was determined by vector expression containing the green fluorescent protein, GFP in transduced cells. The titer was $1{\times}10^7$ Transducing Unit/ml in the GFP expression assay and $8.9{\times}10^7$ molecules/ml in the real-time PCR. Also, for the detection of RCL, we have used a combination method of PCR and p24 antigen detection. First, PBS/psi and VSV-G region in the genomic DNA of transduced cells was detected by PCR assay. Second, transfer and expression of the HIV-1 gag gene was detected by p24 ELISA. In an attempt to amplify any RCL, the transduced cells were cultured for 3 weeks (amplification phase) and the supernatant of amplified transduced cell was used for the second transduction to determine whether a true RCL was present (indicator phase). Analysis of cells and supernatant at day 6 in indicator phase were negative for PBS/psi, VSV-G, and p24 antigen. These results suggest that they are not mobilized and therefore there are no RCL in amplification phase. Thus, real-time PCR is a reliable and sensitive method for titration and RCL detection of lentivirus vector.
Keywords
gene therapy; lentivirus vector; safety; replication competent lentivirus; titer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Klein, S. A., Karsten, S., Ruster, B., Klebba, C., Pape, M., Ottmann, O. G., Hoelzer, D. and Roth, W. K. : Comparison of TaqMan real-time PCR and p24 ELISA for quantification of in vitro HIV-1 replication. J. Virol. Methods 107, 169 (2003)   DOI   ScienceOn
2 Escarpe, P., Zayek, N., Chin, P., Borellini, F., Zufferey, R.. Veres, G. and Kiermer, V. : Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol. Ther. 8, 332 (2003)   DOI   ScienceOn
3 Enca, M. R, Linda, J. W, Anna, O., Kyriacos, A. M. and Nicholas, D. M. : New methods to titrate EIAV-based lentiviral vectors. Mol. Ter. 5, 566 (2002)   DOI   ScienceOn
4 Delenda, C., Audit, M. and Danos, O. : Biosafety issues in lentivector production. Curr. Top. Microbial. Immunol. 261, 123 (2002)
5 Sastry, L., Xu, Y., Johnson, T., Desai, K, Rissing, D., Marsh, J. and Cornetta, K. : Certification assays for HIV-1-based vectors : Frequent passage of Gag sequences without evidence of replication-competent viruses. Mol. Ther. 8, 830 (2003)   DOI   ScienceOn
6 Gatlin, J., Ohlmayer, M. I. and Garcia, J. V. : Detection and titration of lentivirus vector preparations. In Lentivirus gene engineering protocols Vol. 229, M. Federico, Humana Press. Totowa, New Jersey, p57 (2003)
7 Evans, J. T. and Garcia, J. V. : Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum. Gene. Ther. 11, 2331 (2000)   DOI   ScienceOn
8 Armin, B. : Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 33, 164 (2004)   DOI   PUBMED   ScienceOn
9 Sastry. L., Johnson, T., Hobson, M. J., Smucker, B. and Cornetta, K. : Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9, 1155 (2002)   DOI   ScienceOn
10 VandenDriessche, T.. Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D. and Chuah, M. K. : Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen- presenting cells in vivo. Blood. 100, 813 (2002)   DOI   ScienceOn
11 Wilson, C. A., Ng, T. H. and Miller, A. E. : Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vector. Hum. Gene Ther. 8, 869 (1997)   DOI   ScienceOn
12 Herry, I. S., Yoo, E. S. and Sutton, R E. : Characterization and detection of artificial replication-competent lentivirus of altered host range. Mol. Ther. 8, 118 (2003)   DOI   ScienceOn
13 Farson, D., Witt, R., McGuinness, R., Dull, T., Kelly, M., Song, J., Radeke, R., Bukovsky, A., Consiglio, A. and Naldini, L. : A new generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene. Ther. 12, 981 (2001)   DOI   ScienceOn
14 Naldini, L. and Verma, I. M. : Lentiviral vectors. Adv. Virus. Res. 55, 599 (2000)   DOI
15 Naldini, L., Blomer, U., Gallay, P.. Ory, D., Mulligan. R., Gage, F. H., Verma, I. M. and Trono, D. : In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263 (1996)   DOI   ScienceOn
16 Guidance for industry : Supplemental guidance on testing for replication competent retrovirus in retroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors, U.S. Department of health and human services, FDA, CBER (1999)
17 Trono, D. : Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20 (2000)   DOI   PUBMED   ScienceOn
18 Wu, X., Wakefield, J. K., Liu, H., Xiao, H., Kralovics, R., Prchal, J. T. and Kappes, J. C. : Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2, 47 (2000)   DOI   ScienceOn